A case of successive development of possible acute necrotizing encephalopathy after COVID-19 pneumonia
| dc.contributor.author | Pasin Hemachudha | |
| dc.contributor.author | Thanakit Pongpitakmetha | |
| dc.contributor.author | Wanakorn Rattanawong | |
| dc.contributor.author | Poosanu Thanapornsungsuth | |
| dc.contributor.author | Yutthana Joyjinda | |
| dc.contributor.author | Saowalak Bunprakob | |
| dc.contributor.author | Chanida Ruchisrisarod | |
| dc.contributor.author | Thiravat Hemachudha | |
| dc.date.accessioned | 2026-05-08T19:18:05Z | |
| dc.date.issued | 2022-1-1 | |
| dc.description.abstract | COVID-19 infection often results in an excessive inflammatory response with a spectrum of neurological manifestations. Here, we describe an 81-year-old female with severe COVID-19 pneumonia and subsequent alteration of consciousness after high-dose intravenous dexamethasone and remdesivir. A non-contrast head computed tomography (CT) demonstrated bilateral hypodensities involving bilateral cerebellar hemispheres, thalami, cerebral peduncles and medial parieto-occipital areas. There was no improvement and repeat CT showed progression with findings suggestive of acute necrotizing encephalopathy. Interleukin-6 levels were initially normal; however, subsequent levels were found to be markedly elevated. Acute necrotizing encephalopathy associated with COVID-19 may occur in the setting of severe pneumonia and may represent an immune-mediated process involving inflammatory cytokines such as interleukin-6. | |
| dc.identifier.doi | 10.1177/2050313x221083653 | |
| dc.identifier.uri | https://dspace.kmitl.ac.th/handle/123456789/16348 | |
| dc.publisher | SAGE Open Medical Case Reports | |
| dc.subject | Infectious Encephalopathies and Encephalitis | |
| dc.subject | Long-Term Effects of COVID-19 | |
| dc.subject | COVID-19 Clinical Research Studies | |
| dc.title | A case of successive development of possible acute necrotizing encephalopathy after COVID-19 pneumonia | |
| dc.type | Article |